Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 2001 Feb;77(904):82–88. doi: 10.1136/pmj.77.904.82

Non-steroidal anti-inflammatory drugs and gastrointestinal damage—problems and solutions

R Russell 1
PMCID: PMC1741894  PMID: 11161072

Full Text

The Full Text of this article is available as a PDF (107.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allison M. C., Howatson A. G., Torrance C. J., Lee F. D., Russell R. I. Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs. N Engl J Med. 1992 Sep 10;327(11):749–754. doi: 10.1056/NEJM199209103271101. [DOI] [PubMed] [Google Scholar]
  2. Chan F. K., Sung J. J., Chung S. C., To K. F., Yung M. Y., Leung V. K., Lee Y. T., Chan C. S., Li E. K., Woo J. Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers. Lancet. 1997 Oct 4;350(9083):975–979. doi: 10.1016/s0140-6736(97)04523-6. [DOI] [PubMed] [Google Scholar]
  3. Chan F. K., Sung J. J., Suen R., Lee Y. T., Wu J. C., Leung W. K., Chan H. L., Lai A. C., Lau J. Y., Ng E. K. Does eradication of Helicobacter pylori impair healing of nonsteroidal anti-inflammatory drug associated bleeding peptic ulcers? A prospective randomized study. Aliment Pharmacol Ther. 1998 Dec;12(12):1201–1205. doi: 10.1046/j.1365-2036.1998.00434.x. [DOI] [PubMed] [Google Scholar]
  4. DeWitt D. L., Meade E. A., Smith W. L. PGH synthase isoenzyme selectivity: the potential for safer nonsteroidal antiinflammatory drugs. Am J Med. 1993 Aug 9;95(2A):40S–44S. doi: 10.1016/0002-9343(93)90396-7. [DOI] [PubMed] [Google Scholar]
  5. Ehsanullah R. S., Page M. C., Tildesley G., Wood J. R. Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: controlled trial of ranitidine. BMJ. 1988 Oct 22;297(6655):1017–1021. doi: 10.1136/bmj.297.6655.1017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Ekström P., Carling L., Wetterhus S., Wingren P. E., Anker-Hansen O., Lundegårdh G., Thorhallsson E., Unge P. Prevention of peptic ulcer and dyspeptic symptoms with omeprazole in patients receiving continuous non-steroidal anti-inflammatory drug therapy. A Nordic multicentre study. Scand J Gastroenterol. 1996 Aug;31(8):753–758. doi: 10.3109/00365529609010347. [DOI] [PubMed] [Google Scholar]
  7. Faucheron J. L. Toxicity of non-steroidal anti-inflammatory drugs in the large bowel. Eur J Gastroenterol Hepatol. 1999 Apr;11(4):389–392. doi: 10.1097/00042737-199904000-00005. [DOI] [PubMed] [Google Scholar]
  8. Forrest E. H., Russell R. I. Peripheral arthropathies in inflammatory bowel disease. Gut. 1999 Mar;44(3):439–439. doi: 10.1136/gut.44.3.439. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Fu J. Y., Masferrer J. L., Seibert K., Raz A., Needleman P. The induction and suppression of prostaglandin H2 synthase (cyclooxygenase) in human monocytes. J Biol Chem. 1990 Oct 5;265(28):16737–16740. [PubMed] [Google Scholar]
  10. Gabriel S. E., Jaakkimainen L., Bombardier C. Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis. Ann Intern Med. 1991 Nov 15;115(10):787–796. doi: 10.7326/0003-4819-115-10-787. [DOI] [PubMed] [Google Scholar]
  11. Graham D. Y., Agrawal N. M., Roth S. H. Prevention of NSAID-induced gastric ulcer with misoprostol: multicentre, double-blind, placebo-controlled trial. Lancet. 1988 Dec 3;2(8623):1277–1280. doi: 10.1016/s0140-6736(88)92892-9. [DOI] [PubMed] [Google Scholar]
  12. Graham D. Y., White R. H., Moreland L. W., Schubert T. T., Katz R., Jaszewski R., Tindall E., Triadafilopoulos G., Stromatt S. C., Teoh L. S. Duodenal and gastric ulcer prevention with misoprostol in arthritis patients taking NSAIDs. Misoprostol Study Group. Ann Intern Med. 1993 Aug 15;119(4):257–262. doi: 10.7326/0003-4819-119-4-199308150-00001. [DOI] [PubMed] [Google Scholar]
  13. Hawkey C. J. COX-2 inhibitors. Lancet. 1999 Jan 23;353(9149):307–314. doi: 10.1016/s0140-6736(98)12154-2. [DOI] [PubMed] [Google Scholar]
  14. Hawkey C. J., Karrasch J. A., Szczepañski L., Walker D. G., Barkun A., Swannell A. J., Yeomans N. D. Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group. N Engl J Med. 1998 Mar 12;338(11):727–734. doi: 10.1056/NEJM199803123381105. [DOI] [PubMed] [Google Scholar]
  15. Hawkey C. J., Tulassay Z., Szczepanski L., van Rensburg C. J., Filipowicz-Sosnowska A., Lanas A., Wason C. M., Peacock R. A., Gillon K. R. Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study. Helicobacter Eradication for Lesion Prevention. Lancet. 1998 Sep 26;352(9133):1016–1021. doi: 10.1016/s0140-6736(98)04206-8. [DOI] [PubMed] [Google Scholar]
  16. Hudson N., Taha A. S., Russell R. I., Trye P., Cottrell J., Mann S. G., Swanell A. J., Sturrock R. D., Hawkey C. J. Famotidine for healing and maintenance in nonsteroidal anti-inflammatory drug-associated gastroduodenal ulceration. Gastroenterology. 1997 Jun;112(6):1817–1822. doi: 10.1053/gast.1997.v112.pm9178671. [DOI] [PubMed] [Google Scholar]
  17. Kujubu D. A., Fletcher B. S., Varnum B. C., Lim R. W., Herschman H. R. TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J Biol Chem. 1991 Jul 15;266(20):12866–12872. [PubMed] [Google Scholar]
  18. Laine L., Sloane R., Ferretti M., Cominelli F. A randomized double-blind comparison of placebo, etodolac, and naproxen on gastrointestinal injury and prostaglandin production. Gastrointest Endosc. 1995 Nov;42(5):428–433. doi: 10.1016/s0016-5107(95)70045-5. [DOI] [PubMed] [Google Scholar]
  19. Mason J. C. NSAIDs and the oesophagus. Eur J Gastroenterol Hepatol. 1999 Apr;11(4):369–373. doi: 10.1097/00042737-199904000-00002. [DOI] [PubMed] [Google Scholar]
  20. Russell R. I. Endoscopic evaluation of etodolac and naproxen, and their relative effects on gastric and duodenal prostaglandins. Rheumatol Int. 1990;10 (Suppl):17–21. doi: 10.1007/BF02274751. [DOI] [PubMed] [Google Scholar]
  21. Silverstein F. E., Graham D. Y., Senior J. R., Davies H. W., Struthers B. J., Bittman R. M., Geis G. S. Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 1995 Aug 15;123(4):241–249. doi: 10.7326/0003-4819-123-4-199508150-00001. [DOI] [PubMed] [Google Scholar]
  22. Taha A. S., Dahill S., Morran C., Hudson N., Hawkey C. J., Lee F. D., Sturrock R. D., Russell R. I. Neutrophils, Helicobacter pylori, and nonsteroidal anti-inflammatory drug ulcers. Gastroenterology. 1999 Feb;116(2):254–258. doi: 10.1016/s0016-5085(99)70120-4. [DOI] [PubMed] [Google Scholar]
  23. Taha A. S., Hudson N., Hawkey C. J., Swannell A. J., Trye P. N., Cottrell J., Mann S. G., Simon T. J., Sturrock R. D., Russell R. I. Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs. N Engl J Med. 1996 May 30;334(22):1435–1439. doi: 10.1056/NEJM199605303342204. [DOI] [PubMed] [Google Scholar]
  24. Taha A. S., Sturrock R. D., Russell R. I. Mucosal erosions in longterm non-steroidal anti-inflammatory drug users: predisposition to ulceration and relation to Helicobacter pylori. Gut. 1995 Mar;36(3):334–336. doi: 10.1136/gut.36.3.334. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Walan A., Bader J. P., Classen M., Lamers C. B., Piper D. W., Rutgersson K., Eriksson S. Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer. N Engl J Med. 1989 Jan 12;320(2):69–75. doi: 10.1056/NEJM198901123200201. [DOI] [PubMed] [Google Scholar]
  26. Weil J., Colin-Jones D., Langman M., Lawson D., Logan R., Murphy M., Rawlins M., Vessey M., Wainwright P. Prophylactic aspirin and risk of peptic ulcer bleeding. BMJ. 1995 Apr 1;310(6983):827–830. doi: 10.1136/bmj.310.6983.827. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Yeomans N. D., Tulassay Z., Juhász L., Rácz I., Howard J. M., van Rensburg C. J., Swannell A. J., Hawkey C. J. A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group. N Engl J Med. 1998 Mar 12;338(11):719–726. doi: 10.1056/NEJM199803123381104. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES